BELLUS Health Inc (BLU) stock has risen 77.60% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BLU stock a score of 81 out of a possible 100. That rank is mainly influenced by a long-term technical score of 93. BLU's rank also includes a short-term technical score of 77. The fundamental score for BLU is 73. In addition to the average rating from Wall Street analysts, BLU stock has a mean target price of $10.92. This means analysts expect the stock to rise 99.56% over the next 12 months.
News Home
Is BELLUS Health Inc (BLU) Stock Worth a Buy Thursday?
Mentioned in this article
BLU has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on BLU!